PeerVoice is an independent, professional medical publishing concern focused on gathering and reporting information pertaining to clinically relevant advances and developments in the science and practice of medicine. As publishers of PeerVoice Publications, PeerVoice is solely responsible for the selection of publication topics, the preparation of editorial content and the distribution of all materials it publishes.
http://www.peervoice.com
Vijay Ramaswamy, MD, PhD, FRCPC - Managing the Pediatric Patient With Plexiform Neurofibromas: The Case for Systemic Therapy
Visit https://www.peervoice.com/WTV860 to view the entire programme with slides. After completing “Vijay Ramaswamy, MD, PhD, FRCPC - Managing the Pediatric Patient With Plexiform Neurofibromas: The Case for Systemic Therapy”, participants will be able to: Explain which patients with neurofibromatosis type-1 (NF1)-associated plexiform neurofibromas (PN) may require systemic therapy; and Outline practical considerations with MEK inhibitor therapy for NF1-associated PN, including treatment initiation and management of safety concerns.